Home › Celgene Co. (CELG) Upgraded to Strong-Buy at Vetr Inc.
 

Keywords :   


Celgene Co. (CELG) Upgraded to Strong-Buy at Vetr Inc.

2015-12-31 18:25:53| Biotech - Topix.net

The firm presently has a $133.83 price objective on the biopharmaceutical company's stock. Vetr 's price target points to a potential upside of 10.90% from the company's current price.

Tags: inc upgraded celgene celg

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 4A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06CCAI Recognizes 2024 Award Recipients
18.06German court dismisses anti-competitive claims against Tageos
18.06A Request From the A League of Their Own Womens Special Interest Group
More »